What is Duchenne Muscular Dystrophy?
Duchenne Muscular Dystrophy, like all muscular dystrophies, causes weakening of the muscles. DMD is a recessive genetic mutation that occurs on the X chromosome. As a result, it almost exclusively affects boys. Unfortunately for the boys who have been diagnosed with DMD, it is the most severe of all the muscular dystrophies:
- Boys with this disease are diagnosed earlier, usually between 3 and 5 years of age.
- They lose muscle function more quickly, many boys are in wheelchairs by 10-12.
- They die earlier, most boy’s with DMD die in their mid 20’s.
Since Gus’ diagnosis, many well-meaning people have tried to reassure us that they know someone in their 40’s, 50’s or 60’s with muscular dystrophy.
What We’re Funding
At Hope for Gus, we consider ourselves stewards of the money that people donate. We feel incredibly indebted to you, the donor for two reasons:
- We are so appreciative of the fact that you are willing to join us in the fight to save Gus and the tens of thousands of boys like him who are suffering from DMD.
- We are honored that you have entrusted us with your charity dollar. We will do everything in our power to justify that trust. We take it very seriously because it comes down to saving lives.
We work to leverage every donation through collaboration with other DMD organizations. For example, if we are funding worthy research, we may challenge other foundations to match our donation, or we may work with others to match theirs. Our goal, of course is to bring promising research to fruition; to bring treatments to our boys.
Funding through 2020
- DMD Clinic at Umass Worcester – $90,000
- Pandemic relief for DMD families – $10,000
- Eric Olson (University of Texas Southwest) – CRISPR/CAS 9 – $100,000
- Duchenne Clinic at UMass Memorial – $50,000
- Cardiac Project – Expansion of Department of Defense Grant to Dr. Elizabeth McNally, Northwestern University (through PPMD) – $50,000
- Dr. Kevin Flanigan – GalGt2 Gene Therapy Trial – Columbus Children’s – $20,000
- Charley’s Fund Program to Consolidate Research – $15,000
- Eric Hoffman – Reveragen Trial – $37,645
- Daedalus – Dr. McCeachern Stem Cell Research – Utah – $10,000
- U of Reading – Dr. Keith Foster – Repeat Dosing Gene Therapy – $25,000
- Dr. Jerry Mendall – Folistatin Gene Therapy – $29,500